Yield10 Bioscience Secures Regulatory Permits for U.S. and Canadian Sites and Announces Plans for 2020 Field Test Program in ...
May 14 2020 - 4:10PM
Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience
company, today announced that the Company has secured all of the
regulatory permits required to conduct field tests for multiple
traits at sites in the United States and Canada contracted for the
2020 growing season. Yield10’s 2020 Field Test Program will
evaluate several novel traits in Camelina and canola. Planting is
expected to begin in second quarter 2020 pending suitable weather
conditions.
Yield10 utilizes the oilseed plant Camelina sativa to rapidly
evaluate the activity of novel performance traits for development
in Camelina as well as for licensing in key commercial crops,
including canola, soybean, corn and other crops. Yield10 is also
developing Camelina as a platform crop for developing and
commercializing traits to produce nutritional oils and PHA
biomaterials. Yield10’s expertise and development activities in
oilseed crops extends to canola, where the Company is deploying
novel yield traits and developing lines for crossing into elite,
commercial varieties of canola.
“The 2020 Field Test Program will be our largest to date in
terms of the number of traits we will test and the number of field
test sites involved in the U.S. and Canada,” said Dr. Kristi
Snell, Ph.D., Chief Science Officer of Yield10 Bioscience. “Our
team worked very closely with crop regulatory authorities in the
U.S. (USDA-APHIS) and Canada (CFIA) to secure the permits allowing
shipment of seed to our contracted field test sites, marking a
major milestone for Yield10 as we prepare for planting in the weeks
ahead. Our field tests are designed to generate data that will
support our ongoing development efforts for our traits in Camelina,
canola and other commercial crops.”
A summary of the 2020 Field Test Program:
- Camelina/C3004: C3004 is a trait designed to
increase seed yield that has shown promise in previous greenhouse
and growth chamber experiments.
- Camelina/CRISPR E3902: E3902 is a CRISPR
genome-edited trait designed to boost oil content. This line
gave positive results in 2019 field tests.
- Camelina/CRISPR C3007: C3007 is a CRISPR
genome-edited trait designed to boost oil content. This is the
first season field testing the trait.
- Camelina/C3014 and C3015 :Yield10 has designed
a novel trait and reprogrammed Camelina to produce PHA biomaterial
as a third seed product. This is the first season field testing the
trait.
- Canola/C3004: C3004 is a trait designed to
increase seed yield. This is the first season field testing the
trait in canola.
- Canola/C3003: Yield10 will grow 14 new
canola/C3003 commercial quality lines for seed bulk up in the field
in 2020 and plans to field test to measure performance of these
lines in 2021. C3003 is a seed yield trait.
In the field tests of its novel traits in Camelina and canola,
Yield10 will monitor key agronomic and growth parameters of the
plants throughout the growth period. Yield10 also plans to evaluate
seed yield, oil content, PHA content and/or other parameters of the
traits as appropriate after seed harvest. The program will also
generate field grown seed for subsequent field studies. The field
tests are designed to generate data on the activity of the novel
traits and to advance the development of the traits toward
commercialization.
About Yield10 Bioscience
Yield10 Bioscience, Inc. is an agricultural bioscience company
developing crop innovations to improve crop yields and enhance
sustainable global food security. The Company utilizes its
proprietary “GRAIN“ (Gene Ranking Artificial Intelligence Network)
gene discovery platform to identify gene targets to improve yield
performance and value in major commercial food and feed crops.
Yield10 uses its Camelina oilseed platform to rapidly evaluate and
field test new trait leads enabling the translation of promising
new traits into the major commercial crops. As a path toward
commercialization, Yield10 is pursuing a partnering approach with
agricultural companies to drive new traits into development in
crops such as canola, soybean and corn. The Company is also
developing Camelina as a platform crop for producing nutritional
oils and specialty products such as PHA biomaterials for use in
water treatment and bioplastics. Yield10 is headquartered in
Woburn, MA and has an Oilseeds Center of Excellence in Saskatoon,
Canada.
For more information about the company, please visit
www.yield10bio.com, or follow the Company on Twitter, Facebook and
LinkedIn.
(YTEN-G)
Safe Harbor for Forward-Looking
Statements
This press release contains forward-looking statements which are
made pursuant to the safe harbor provisions of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. The forward-looking
statements in this release do not constitute guarantees of future
performance. Investors are cautioned that statements in this press
release which are not strictly historical, including, without
limitation, statements regarding the Company’s intentions with
regard to plans to conduct field tests with Camelina and canola in
2020, the results and outcome of those tests, the ability to use
the results of the tests in future studies, and expectations with
regard to the timing of (1) planting for its 2020 field tests, and
(2) reporting results of the field tests, constitute
forward-looking statements. Such forward-looking statements are
subject to a number of risks and uncertainties that could cause
actual results to differ materially from those anticipated,
including the risks and uncertainties detailed in Yield10
Bioscience's filings with the Securities and Exchange Commission.
Yield10 assumes no obligation to update any forward-looking
information contained in this press release or with respect to the
matters described herein.
Contacts: Yield10
Bioscience:Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com
Investor Relations: Bret Shapiro, (561) 479-8566,
brets@coreir.comManaging Director, CORE IR
Media Inquiries: Eric Fischgrund, eric@fischtankpr.com FischTank
Marketing and PR
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Apr 2023 to Apr 2024